Agios Pharmaceuticals News

Leerink Partners Downgrades Agios Pharmaceuticals(AGIO.US) to Hold Rating, Cuts Target Price to $56

Moomoo NewsSep 27 06:31 ET

Agios Pharmaceuticals Downgraded to Market Perform From Outperform at Leerink

TipRanksSep 27 06:17 ET

BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $57

Moomoo NewsSep 27 05:32 ET

Piper Sandler Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $56

Moomoo NewsSep 26 14:32 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaSep 19 09:08 ET

RBC Capital Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsSep 19 07:33 ET

Piper Sandler Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $56

Moomoo NewsSep 10 14:32 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaAug 2 15:41 ET

TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating

Moomoo NewsAug 2 08:36 ET

RBC Capital Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $55

Moomoo NewsAug 2 07:31 ET

TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating

Moomoo NewsAug 1 17:31 ET

Piper Sandler Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsJul 23 07:31 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaJun 13 17:08 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaJun 4 09:33 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaMay 3 11:50 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaApr 9 08:27 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaFeb 23 12:33 ET

Agios Pharmaceuticals Analyst Ratings

BenzingaFeb 16 11:55 ET

RBC Trims Price Target on Agios Pharmaceuticals to $42 From $43, Keeps Outperform Rating

MT NewswiresFeb 16 07:52 ET

Goldman Sachs Maintains Neutral on Agios Pharmaceuticals, Lowers Price Target to $28

BenzingaNov 3, 2023 10:18 ET